IMMX vs. AXTI
IMMX (Immix Biopharma, Inc.) and AXTI (AXT, Inc.) are both stocks. IMMX operates in Biotechnology (Healthcare), while AXTI operates in Semiconductor Equipment & Materials (Technology). Over the past 3 years, IMMX returned 60.54%/yr vs 212.99%/yr for AXTI. At a 0.15 correlation, their price movements are largely independent.
Performance
IMMX vs. AXTI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IMMX achieves a 61.38% return, which is significantly lower than AXTI's 552.60% return.
IMMX
- 1D
- 0.90%
- 1M
- -10.97%
- YTD
- 61.38%
- 6M
- 103.37%
- 1Y
- 300.00%
- 3Y*
- 60.54%
- 5Y*
- —
- 10Y*
- —
AXTI
- 1D
- -3.74%
- 1M
- 0.66%
- YTD
- 552.60%
- 6M
- 829.44%
- 1Y
- 6,085.51%
- 3Y*
- 212.99%
- 5Y*
- 58.76%
- 10Y*
- 40.50%
IMMX vs. AXTI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IMMX Immix Biopharma, Inc. | 61.38% | 137.73% | -68.21% | 202.18% | -35.67% | -3.00% |
AXTI AXT, Inc. | 552.60% | 653.46% | -9.58% | -45.21% | -50.28% | 12.52% |
Correlation
The correlation between IMMX and AXTI is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Dec 17, 2021 | 0.15 |
Fundamentals
IMMX:
$467.32M
AXTI:
$5.69B
IMMX:
-$0.90
AXTI:
-$0.30
IMMX:
5.54
AXTI:
20.97
IMMX:
$0.00
AXTI:
$95.89M
IMMX:
-$90.63K
AXTI:
$20.46M
IMMX:
-$35.73M
AXTI:
-$7.63M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IMMX vs. AXTI — Risk / Return Rank
IMMX
AXTI
IMMX vs. AXTI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Immix Biopharma, Inc. (IMMX) and AXT, Inc. (AXTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IMMX | AXTI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.58 | 45.71 | -42.13 |
Sortino ratioReturn per unit of downside risk | 3.56 | 6.96 | -3.40 |
Omega ratioGain probability vs. loss probability | 1.41 | 1.87 | -0.46 |
Calmar ratioReturn relative to maximum drawdown | 7.59 | 160.12 | -152.53 |
Martin ratioReturn relative to average drawdown | 16.73 | 490.82 | -474.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IMMX | AXTI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.58 | 45.71 | -42.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.62 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.49 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.19 | 0.11 | +0.08 |
Drawdowns
IMMX vs. AXTI - Drawdown Comparison
The maximum IMMX drawdown since its inception was -88.89%, smaller than the maximum AXTI drawdown of -98.57%. Use the drawdown chart below to compare losses from any high point for IMMX and AXTI.
Loading charts...
Drawdown Indicators
| IMMX | AXTI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.89% | -98.57% | +9.68% |
Max Drawdown (1Y)Largest decline over 1 year | -39.84% | -38.65% | -1.19% |
Max Drawdown (3Y)Largest decline over 3 years | -81.57% | -78.52% | -3.05% |
Max Drawdown (5Y)Largest decline over 5 years | — | -90.57% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -92.45% | — |
Current DrawdownCurrent decline from peak | -24.10% | -24.23% | +0.13% |
Average DrawdownAverage peak-to-trough decline | -58.71% | -82.33% | +23.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.03% | 12.58% | +5.45% |
Volatility
IMMX vs. AXTI - Volatility Comparison
The current volatility for Immix Biopharma, Inc. (IMMX) is 20.91%, while AXT, Inc. (AXTI) has a volatility of 37.30%. This indicates that IMMX experiences smaller price fluctuations and is considered to be less risky than AXTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IMMX | AXTI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.91% | 37.30% | -16.39% |
Volatility (6M)Calculated over the trailing 6-month period | 60.52% | 112.04% | -51.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 86.61% | 135.60% | -48.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 109.41% | 95.88% | +13.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 109.41% | 82.31% | +27.10% |
Dividends
IMMX vs. AXTI - Dividend Comparison
Neither IMMX nor AXTI has paid dividends to shareholders.
Financials
IMMX vs. AXTI - Financials Comparison
This section allows you to compare key financial metrics between Immix Biopharma, Inc. and AXT, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IMMX and AXTI have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXTI has higher volatility (37.30%) compared to IMMX (20.91%). In terms of maximum drawdown, IMMX dropped -88.89% vs AXTI's -98.57%.
AXTI currently has the higher Sharpe Ratio (45.71 vs 3.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IMMX and AXTI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer